Shariat, S. F., Savage, C., Chromecki, T. F., Sun, M., Scherr, D. S., Lee, R. K., . . . Vickers, A. J. (2011). Assessing the clinical benefit of NMP22 in the surveillance of patients with non–muscle-invasive bladder cancer and negative cytology: A decision-curve analysis.
Stile di citazione ChicagoShariat, Shahrokh F., et al. Assessing the Clinical Benefit of NMP22 in the Surveillance of Patients With Non–muscle-invasive Bladder Cancer and Negative Cytology: A Decision-curve Analysis. 2011.
Citazione MLAShariat, Shahrokh F., et al. Assessing the Clinical Benefit of NMP22 in the Surveillance of Patients With Non–muscle-invasive Bladder Cancer and Negative Cytology: A Decision-curve Analysis. 2011.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.